ALC
Price
$80.17
Change
+$1.26 (+1.60%)
Updated
Sep 5 closing price
Capitalization
39.41B
67 days until earnings call
ESLOY
Price
$152.42
Change
+$0.20 (+0.13%)
Updated
Sep 5 closing price
Capitalization
139.91B
40 days until earnings call
Interact to see
Advertisement

ALC vs ESLOY

Header iconALC vs ESLOY Comparison
Open Charts ALC vs ESLOYBanner chart's image
Alcon
Price$80.17
Change+$1.26 (+1.60%)
Volume$1.67M
Capitalization39.41B
EssilorLuxottica
Price$152.42
Change+$0.20 (+0.13%)
Volume$30.31K
Capitalization139.91B
ALC vs ESLOY Comparison Chart in %
Loading...
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALC vs. ESLOY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Hold and ESLOY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ALC: $80.17 vs. ESLOY: $152.42)
Brand notoriety: ALC and ESLOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALC: 83% vs. ESLOY: 31%
Market capitalization -- ALC: $39.41B vs. ESLOY: $139.91B
ALC [@Pharmaceuticals: Other] is valued at $39.41B. ESLOY’s [@Pharmaceuticals: Other] market capitalization is $139.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileESLOY’s FA Score has 3 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • ESLOY’s FA Score: 3 green, 2 red.
According to our system of comparison, ESLOY is a better buy in the long-term than ALC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 5 TA indicator(s) are bullish while ESLOY’s TA Score has 3 bullish TA indicator(s).

  • ALC’s TA Score: 5 bullish, 5 bearish.
  • ESLOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALC is a better buy in the short-term than ESLOY.

Price Growth

ALC (@Pharmaceuticals: Other) experienced а +0.45% price change this week, while ESLOY (@Pharmaceuticals: Other) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

ALC is expected to report earnings on Nov 12, 2025.

ESLOY is expected to report earnings on Oct 16, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($140B) has a higher market cap than ALC($39.4B). ESLOY has higher P/E ratio than ALC: ESLOY (50.82) vs ALC (37.12). ESLOY YTD gains are higher at: 30.529 vs. ALC (-5.560). ESLOY has higher annual earnings (EBITDA): 6.71B vs. ALC (1.53B). ESLOY has more cash in the bank: 3.16B vs. ALC (1.41B). ALC has less debt than ESLOY: ALC (5.2B) vs ESLOY (14B). ESLOY has higher revenues than ALC: ESLOY (27.2B) vs ALC (9.93B).
ALCESLOYALC / ESLOY
Capitalization39.4B140B28%
EBITDA1.53B6.71B23%
Gain YTD-5.56030.529-18%
P/E Ratio37.1250.8273%
Revenue9.93B27.2B36%
Total Cash1.41B3.16B45%
Total Debt5.2B14B37%
FUNDAMENTALS RATINGS
ALC vs ESLOY: Fundamental Ratings
ALC
ESLOY
OUTLOOK RATING
1..100
1272
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
6115
SMR RATING
1..100
8495
PRICE GROWTH RATING
1..100
8149
P/E GROWTH RATING
1..100
6630
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOY's Valuation (33) in the null industry is somewhat better than the same rating for ALC (74) in the Hospital Or Nursing Management industry. This means that ESLOY’s stock grew somewhat faster than ALC’s over the last 12 months.

ESLOY's Profit vs Risk Rating (15) in the null industry is somewhat better than the same rating for ALC (61) in the Hospital Or Nursing Management industry. This means that ESLOY’s stock grew somewhat faster than ALC’s over the last 12 months.

ALC's SMR Rating (84) in the Hospital Or Nursing Management industry is in the same range as ESLOY (95) in the null industry. This means that ALC’s stock grew similarly to ESLOY’s over the last 12 months.

ESLOY's Price Growth Rating (49) in the null industry is in the same range as ALC (81) in the Hospital Or Nursing Management industry. This means that ESLOY’s stock grew similarly to ALC’s over the last 12 months.

ESLOY's P/E Growth Rating (30) in the null industry is somewhat better than the same rating for ALC (66) in the Hospital Or Nursing Management industry. This means that ESLOY’s stock grew somewhat faster than ALC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCESLOY
RSI
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
43%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 10 days ago
56%
Bearish Trend 5 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
40%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UJB78.620.86
+1.11%
ProShares Ultra High Yield
FEM26.610.29
+1.10%
First Trust Emerging Mrkts AlphaDEX® ETF
DNP9.850.04
+0.41%
DNP Select Income Fund
CALI50.580.04
+0.08%
iShares Short-Term CA Muni Act ETF
XOCT36.580.01
+0.02%
FT Vest US Eq Enh & Mod Buf ETF-Oct

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+0.13%
ESLOF - ESLOY
58%
Loosely correlated
-2.34%
QGEN - ESLOY
43%
Loosely correlated
+1.08%
ALC - ESLOY
38%
Loosely correlated
+1.60%
SMMNY - ESLOY
38%
Loosely correlated
+0.80%
CRL - ESLOY
35%
Loosely correlated
+1.04%
More